La Sindrome cardiorenale nel paziente critico

Similar documents
Οξεία καρδιακή ανεπάρκεια: Ποιες παράμετροι συμβάλλουν στη διαστρωμάτωση κινδύνου των ασθενών;

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )

SCOMPENSO CARDIACO: IL PUNTO DELLA RICERCA

The right heart: the Cinderella of heart failure

ACUTE HEART FAILURE. Julie Gorchynski MD, MSc, FACEP, FAAEM. Department of Emergency Medicine Emergency Residency Program UTHSC, San Antonio TCEP 2014

Radboud University Nijmegen Medical Centre Why measure cardiac output in critically ill children?

Cardiogenic Shock. Carlos Cafri,, MD

Albumina nel paziente critico. Savona 18 aprile 2007

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?

WHY ADMINISTER CARDIOTONIC AGENTS?

Acute Coronary Syndrome

Treating the patient with acute heart failure. What do we really know? Principles of acute heart failure treatment

AllinaHealthSystem 1

Low Cardiac Output in the Pediatric Patient

Ramani GV et al. Mayo Clin Proc 2010;85:180-95

Objectives. Systolic Heart Failure: Definitions. Heart Failure: Historical Perspective 2/7/2009

Constrictive/Restrictive Cardiomyopathies: Diagnosis and Management Update; Radiation Induced Heart Disease. Alexander (Sandy) Dick, MD

Ventricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC

Cardiovascular Management of Septic Shock

Management of Heart Failure in Adult with Congenital Heart Disease

Keynote Address II Managing Acute Heart Failure: What Can We Do to Improve Outcomes?

Heart failure: what should be changed? Prof. Gerasimos Filippatos Attikon University Hospital

Cardiogenic shock: Current management

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure

Counterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece

Carlo Budano. Closed loop physiological stimulation: from the pacemaker patient to the patient with an ICD

Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension

Lnformation Coverage Guidance

Patterns of Left Ventricular Remodeling in Chronic Heart Failure: The Role of Inadequate Ventricular Hypertrophy

Fattori condizionanti la sopravvivenza nel paziente con scompenso di cuore

Management of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist

Atrial dyssynchrony syndrome: An overlooked cause of heart failure with normal ejection fraction

Impedance Cardiography (ICG) Application of ICG in Intensive Care and Emergency

Rotation: Heart Failure/VAD/Cardiac Transplantation

The Treatment Targets in Acute Decompensated Heart Failure

Heart Failure and Renal Failure. Gerasimos Filippatos, MD, FESC, FHFA President HFA

Hemodynamic improvement upon levosimendan treatment in low cardiac output patients following coronary artery bypass graft

DIAGNOSIS AND MANAGEMENT OF ACUTE HEART FAILURE

DECLARATION OF CONFLICT OF INTEREST

Οξεία Καρδιακή Ανεπάρκεια: Κλινική εικόνα, ταξινόμηση κινδύνου & προγνωστικοί δείκτες

Lo scompenso cardiaco: le riammissioni, un problema in parte evitabile?

Cath Lab Essentials: Basic Hemodynamics for the Cath Lab and ICU

DECLARATION OF CONFLICT OF INTEREST

Scompenso cardiaco e F A : ruolo della ablazione transcatetere. Prof. Fiorenzo Gaita

Acute heart failure syndromes: clinical challenges. Pathophysiology. ESC Congress August. Paris, France. Marco Metra

A Study Conducted At A Tertiary Care Teaching Institute in Chennai, on The Clinical And Etiological Profile Of Patients With Acute Heart Failure.

Management of Cardiogenic shock. Prof. Christian JM Vrints

The Who, How and When of Advanced Heart Failure Therapies. Disclosures. What is Advanced Heart Failure?

TOPIC : Cardiogenic Shock

Outline. Congenital Heart Disease. Special Considerations for Special Populations: Congenital Heart Disease

Percutaneous Mechanical Circulatory Support Devices

Mechanical Support in the Failing Fontan-Kreutzer

Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco

DECLARATION OF CONFLICT OF INTEREST

Using Lung Ultrasound to Diagnose and Manage Acute Heart Failure

Pulmonary Embolectomy:

Acute Circulatory Support Should We or Shouldn t We?

The development of cardiogenic shock portends an extremely poor prognosis. Cardiogenic Shock: A Lethal Complication of Acute Myocardial Infarction

PHARMACOLOGICAL MANAGEMENT OF CARDIOGENIC SHOCK

Lo scompenso cardiaco avanzato nel paziente anziano comorbido

5 Important Things to Know About Heart Failure. Kia Afshar, MD

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Cardiology. the Sounds: #7 HCM. LV Outflow Obstruction: Aortic Stenosis. (Coming Soon - HCM)

Μη φαρμακευτική θεραπεία στην Χρόνια Καρδιακή Ανεπάρκεια Νεότερες συσκευές. Ξυδώνας Σωτήριος, MD, PhD, FESC

During exercise the heart rate is 190 bpm and the stroke volume is 115 ml/beat. What is the cardiac output?

Βασιλική Κατσή. Καρδιολόγος ΓNA Ιπποκράτειο

Ruolo dei Marcatori Bioumorali nello scompenso cardiaco

4/22/2016 Updated. AllinaHealthSystem. Cardiogenic Shock: Definition. No Disclosures. Cardiogenic Shock: Declining (But Still High) Case Fatality Rate

A case of post myocardial infarction ventricular septal rupture CHRISTOFOROS KOBOROZOS, MD

Relax and Learn At the Farm 2012

CABG alone. It s enough? / Μόνο η αορτοστεφανιαία παράκαμψη είναι αρκετή;

Case Presentations TAVR: The Good Bad and The Ugly

Οξύ στεφανιαίο σύνδρομο και καρδιογενής καταπληξία. Επεμβατική προσέγγιση. Σωτήριος Πατσιλινάκος Κωνσταντοπούλειο Γ.Ν. Ν. Ιωνίας

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

The Pathophysiology of Cardiogenic Shock Knowledge Gaps & Opportunities

Managing Hypertension in the Perioperative Arena

Surgical Thrombectomy for PE: Is it Making a Comeback

Chronic Primary Mitral Regurgitation

Acute Mechanical Circulatory Support Right Ventricular Support Devices

Surgical Options for Advanced Heart Failure

Tri-City Cardiology Consultants FIFTH ANNUAL SYMPOSIUM

Tissue is the Issue. PEEP CPAP FiO2 HFNC PSV HFNC. DO 2 = CO [(Hb x 1.34) SaO PaO 2 ] perfusione

Cardiology. Objectives. Chapter

High Risk PCI for Heart Failure

Ischemic Mitral Valve Disease: Repair, Replace or Ignore?

Therapeutic Targets and Interventions

Fibrillazione atriale e scompenso: come interrompere il circolo vizioso.

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

Emergency surgery in acute coronary syndrome

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

Topic Page: congestive heart failure

Left ventricular diastolic function and filling pressure in patients with dilated cardiomyopathy

CARDIOGENIC SHOCK. Antonio Pesenti. Università degli Studi di Milano Bicocca Azienda Ospedaliera San Gerardo Monza (MI)

Heart Failure Guidelines For your Daily Practice

Heart Transplantation in Seniors European View

Medical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011

Sleep Disordered Breathing and HH with Preserved Ejection Fraction:

Pre-discussion questions

Medical Management of Acute Heart Failure

Surgical Management of TOF in Adults. Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital

Transcription:

La Sindrome cardiorenale nel paziente critico Lo scompenso cardiaco nel paziente postcardiochirurgico F.L. Lorini

DEFINITION AHF is a critical inability of the myocardium to maintain a cardiac output sufficient to meet the demands of the peripheral circulation.

DEFINITION AHF is a critical inability of the myocardium to maintain a cardiac output sufficient to meet the demands of the peripheral circulation. with or without previous cardiac disease. systolic or diastolic dysfunction abnormalities in cardiac rhythm pre-load and after-load mismatch

DEFINITION AHF is a critical inability of the myocardium to maintain a cardiac output sufficient to meet the demands of the peripheral circulation. It is often life threatening and requires urgent treatment.

Acute Exacerbations May Contribute to the Progression of the Disease Ventricular function Acute event With each event, hemodynamic alterations and myocardial damage contribute to progressive ventricular dysfunction Time From Gheorghiade. Am J Cardiol 2005 (modified)

Complications in Cardiac Surgery 18 12 11 4 3 5 CIrculatory I stroke lung kidney bleeding sepsis

REVIEW Clinical Profiles According to ESC Guidelines Clinical review: Practical recommendations on the management Italian of perioperative Survey on Acute Heart heart Failure failure in cardiac surgery Cardiac surgery failure 19% Cardiac surgery normal 81%

Clinical Profiles According to ESC Guidelines Italian Survey on Acute Heart Failure

Clinical Profiles According to ESC Guidelines Italian Survey on Acute Heart Failure 30,00 22,50 In Hospital Death 25,4 15,00 7,50 0 3,2 6,8 5,1 Hypertensive HF cardiogenic shock Pulmonary edema Acute decompensated HF

Clinical Profiles According to ESC Guidelines Italian Survey on Acute Heart Failure 30,00 In Hospital Death 50,00 6 Months Death 22,50 25,4 37,50 43,0 15,00 7,50 0 3,2 6,8 5,1 25,00 12,50 0 12,0 22,0 23,0 Hypertensive HF cardiogenic shock Pulmonary edema Acute decompensated HF Hypertensive HF cardiogenic shock Pulmonary edema Acute decompensated HF

REVIEW Clinical review: Practical recommendations on the management of perioperative heart failure in cardiac surgery Figure 1. Kaplan Meier curves showing survival rates of ICU patients with different acute heart failure (HF) syndromes over time, starting at the day of ICU admission. The small vertical lines indicate the time points when patients had their last follow-up. The survival curves between the groups are signifi cantly different (log rank P < 0.001). Data were derived from [10].

Hemodynamic variables during acute HF Cardiac Index Wedge Pressure 50 6 40 4 CI l/min/m 2 * 2 * 30 Wedge mmhg 20 10 0 Cardiogenic shock Pulmonary edema HTN crisis Exacerbated Systolic HF Normal Septic shock 0 Cotter et al: Eur J Heart Fail, 2003

Hemodynamic variables during acute HF 12000 Systemic vascular resistance index (Dyne/ m 2 ) 8000 SVR 4000 0 Cardiogenic shock Pulmonary edema HTN crisis Exacerbated Systolic HF Normal Septic shock Cotter et al: Eur J Heart Fail, 2003

Diagnosis of different clinical syndromes

Diagnosis of different clinical syndromes Acute CHF

Diagnosis of different clinical syndromes Acute CHF Cardiogenic shock

Diagnosis of different clinical syndromes Acute CHF Pulmonary edema Cardiogenic shock

Diagnosis of different clinical syndromes Acute CHF Pulmonary edema Cardiogenic shock RV failure

Diagnosis of different clinical syndromes Acute CHF Pulmonary edema Cardiogenic shock RV failure High output failure

Diagnosis of different clinical syndromes Acute CHF Pulmonary edema Cardiogenic shock Hypertensive AHF RV failure High output failure

INSUFFICIENZA VASCOLARE O CARDIACA? 1. Insorgenza acuta, conservata FE 2. Insorgenza meno acuta, Fe depressa 3. Insuff. cardiaca + ipoperfusione

Danno miocardico bioumorale:tnf-endotelio-peptidi meccanico-adattamento

LIVELLI DI CITOCHINE E GRAVITA DELLO SCOMPENSO Aukrust P; Am J Cardiol 1999; 83: 376-382

LIVELLI DI CITOCHINE E GRAVITA DELLO SCOMPENSO Aukrust P; Am J Cardiol 1999; 83: 376-382 20,00 TNF AO CS ICD 18 15,00 16 15 10,00 12 11 12 5,00 8 7 7 0 NYHA II NYHA III NYHA IV

LIVELLI DI CITOCHINE E GRAVITA DELLO SCOMPENSO Aukrust P; Am J Cardiol 1999; 83: 376-382 TNF IL 6 pcg/ml 20,00 AO CS ICD 8,00 AO CS ICD 8 15,00 18 16 15 6,00 6 7 7 6 10,00 12 11 12 4,00 5 5,00 8 7 7 2,00 2 0 NYHA II NYHA III NYHA IV 0 1 NYHA II 1 NYHA III NYHA IV

LIVELLI DI CITOCHINE E GRAVITA DELLO SCOMPENSO Bonaduce D, Am Hearth J 2000; 1

LIVELLI DI CITOCHINE E GRAVITA DELLO SCOMPENSO 6,00 4,50 3,00 1,50 0 IL-10 pcg/ml 5,1 3,0 3,2 1,0 Controls NYHA II NYHA III NYHA IV Bonaduce D, Am Hearth J 2000; 1

LIVELLI DI CITOCHINE E GRAVITA DELLO SCOMPENSO 6,00 4,50 3,00 IL-10 pcg/ml 5,1 3,0 3,2 Controls NYHA II NYHA III NYHA IV 40 30 20 31 25 23 Controls NYHA II NYHA III NYHA IV 1,50 0 1,0 10 0 10 Bonaduce D, Am Hearth J 2000; 1

LIVELLI DI CITOCHINE E GRAVITA DELLO SCOMPENSO 6,00 4,50 3,00 IL-10 pcg/ml 5,1 3,0 3,2 Controls NYHA II NYHA III NYHA IV 40 30 20 31 25 23 Controls NYHA II NYHA III NYHA IV 1,50 0 1,0 10 0 10 50 38 25 41 32 25 Controls NYHA II NYHA III NYHA IV 13 14 0 Bonaduce D, Am Hearth J 2000; 1

Kirklin JK, Kirklin JW. Cardiopulmonary bypass for cardiac surgery. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest, 5th ed. Philadelphia: WB Saunders, 1990; 1107-25 Kirklin and colleagues found that plasma C3a levels measured 3 h post-cpb could predict the occurrence of complications.

Kirklin JK, Kirklin JW. Cardiopulmonary bypass for cardiac surgery. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest, 5th ed. Philadelphia: WB Saunders, 1990; 1107-25 Kirklin and colleagues found that plasma C3a levels measured 3 h post-cpb could predict the occurrence of complications. 40 30 20 10 CPB SURGERY 0 30 60 90 120 180

Kirklin JK, Kirklin JW. Cardiopulmonary bypass for cardiac surgery. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest, 5th ed. Philadelphia: WB Saunders, 1990; 1107-25 Kirklin and colleagues found that plasma C3a levels measured 3 h post-cpb could predict the occurrence of complications. 40 30 20 10 CPB SURGERY 0 4 2 30 60 90 120 180

Kirklin JK, Kirklin JW. Cardiopulmonary bypass for cardiac surgery. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest, 5th ed. Philadelphia: WB Saunders, 1990; 1107-25 Kirklin and colleagues found that plasma C3a levels measured 3 h post-cpb could predict the occurrence of complications. 40 30 20 10 14 CPB SURGERY 0 4 4 2 30 60 90 120 180

Kirklin JK, Kirklin JW. Cardiopulmonary bypass for cardiac surgery. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest, 5th ed. Philadelphia: WB Saunders, 1990; 1107-25 Kirklin and colleagues found that plasma C3a levels measured 3 h post-cpb could predict the occurrence of complications. 40 30 20 10 0 14 CPB 4 4 2 25 30 60 90 120 180 7 SURGERY

Kirklin JK, Kirklin JW. Cardiopulmonary bypass for cardiac surgery. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest, 5th ed. Philadelphia: WB Saunders, 1990; 1107-25 Kirklin and colleagues found that plasma C3a levels measured 3 h post-cpb could predict the occurrence of complications. 40 30 20 10 0 14 CPB 4 4 2 25 30 60 90 120 180 7 SURGERY 30 8

Kirklin JK, Kirklin JW. Cardiopulmonary bypass for cardiac surgery. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest, 5th ed. Philadelphia: WB Saunders, 1990; 1107-25 Kirklin and colleagues found that plasma C3a levels measured 3 h post-cpb could predict the occurrence of complications. 40 30 20 10 0 14 CPB 4 4 2 25 30 60 90 120 180 7 SURGERY 30 8 35 9

ENDOTELINA Yanagisawa M, Nature;1988;332:411-15

VASODILATAZIONE ARTERIOSA DOPO INFUSIONE DI L-NMMA Belardinelil R. J Cardiol 2001; 81:1-8

DISFUNZIONE ENDOTELIALE NELLO SCOMPENSO Belardinelli R. Int J Cardiol 2001; 81:1-8

PRINCIPALI MECCANISMI DETERMINANTI DELLA FORZA DI CONTRAZIONE DEL MIOCARDIO

The management strategy Drugs O2 Fluid Balance Surgery/Devices

Cellular architecture: the sarcomere at TITIN Passive tension Z disk M line Thin filament: ACTIN Active tension Thick filament: MYOSIN

The variation in isometric tension with sarcomere length in muscle fibers Tension peak at 2.2 µm of length

RELAZIONE VELOCITÀ DI ACCORCIAMENTO CARICO DI UN MUSCOLO PAILLARE Braunwald E, Mechanism of contraction 2nd Edition 1976

EFFETTI DELLA NORADRENALINA (NE) SULLA RELAZIONE F/V NEL MUSCOLO PAPILLARE Braunwald E, Mechanism of contraction 2nd Edition 1976

RELAZIONE TRA CONSUMO MIOCARDICO DI O2 ED ENERGIA MECCANICA PRODOTTA 0,08 0,06 0,04 0,02 0 0 500 1000 GIBBS CL, Am J Physiol 1985;249:H199-06

RELAZIONE TRA CONSUMO MIOCARDICO DI O2 ED ENERGIA MECCANICA PRODOTTA MVO2 0,08 0,06 NORMALE >>CONTRATTILITA SCOMPENSO 0,04 0,02 0 0 500 1000 APV (Joule*beat) GIBBS CL, Am J Physiol 1985;249:H199-06

EFFETTI EMODINAMICI INDOTTI DALL ESPANSIONE ACUTA DI VOLUME SOGGETTI NORMALI VOLPE M, CIRCULATION 1995;92:2511-18 CARDIOMIOPATIA DILATATIVA IN CLASSE NYHA I-II

FISIOPATOLOGIA E TERAPIA SIGNIFICATO PROGNOSTICO DELLE CATECOLAMINE CARDIACHE > Kaye DM J Am Coll Cardiol 1995; 26:1257-63

FISIOPATOLOGIA E TERAPIA SOPRAVVIVENZA E LIVELLI DI NORADRENALINA Cohn JN, N Engl J Med 1984;311:822

www. Anestesiacardiovascolare.it

Complications in Cardiac Surgery 18 12 11 4 3 5 CIrculatory I stroke lung kidney bleeding sepsis

STATUS OF THE ART Buckberg G. Congestive heart failure: treat the disease, not the symptoms return to normalcy J Thorac Cardiovasc Surg 2001;121:628-37